Literature DB >> 19276456

Low-dose anthracyclines may block HIF-1 and stop tumor growth.

Karyn Hede.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19276456     DOI： 10.1093/jnci/djp052

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Hypoxia-induced angiogenesis: good and evil.

Authors:  Bryan L Krock; Nicolas Skuli; M Celeste Simon
Journal:  Genes Cancer       Date:  2011-12

2.  Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.

Authors:  Max Yan; Nicholas Jene; David Byrne; Ewan K A Millar; Sandra A O'Toole; Catriona M McNeil; Gaynor J Bates; Adrian L Harris; Alison H Banham; Robert L Sutherland; Stephen B Fox
Journal:  Breast Cancer Res       Date:  2011-04-26       Impact factor: 6.466

3.  Silencing HIF-1α reduces the adhesion and secretion functions of acute leukemia hBMSCs.

Authors:  Zeng Dong-Feng; Liu Ting; Chang Cheng; Zhang Xi; Liang Xue; Chen Xing-Hua; Kong Pei-Yan
Journal:  Braz J Med Biol Res       Date:  2012-10       Impact factor: 2.590

4.  Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy.

Authors:  David Warther; Ying Xiao; Fangting Li; Yuqin Wang; Kristyn Huffman; William R Freeman; Michael Sailor; Lingyun Cheng
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.